1 results match your criteria: "and Toronto Centre for Advanced Reproductive Technology Fertility Partners[Affiliation]"

Basic understanding of gonadotropin-releasing hormone-agonist triggering.

Fertil Steril

April 2015

Division of Reproductive Sciences, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, and Toronto Centre for Advanced Reproductive Technology Fertility Partners, Toronto, Ontario, Canada. Electronic address:

A single bolus of human chorionic gonadotropin (hCG) at midcycle has been the gold standard for triggering final oocyte maturation and ovulation in assisted reproductive technology cycles. More recently, gonadotropin-releasing hormone (GnRH)-agonist (GnRH-a) triggering has been introduced. The GnRH-a trigger may allow a more physiologic surge of both luteinizing hormone (LH) and follicle-stimulating hormone, although whether the combined surge will result in improved oocyte and embryo quality remains to be seen.

View Article and Find Full Text PDF